去乙酰毛花苷注射液市场报告：2031 年趋势、预测与竞争分析

由于医院和诊所市场机会的推动，全球去毛花苷注射剂市场前景光明。预计2025年至2031年期间，全球去毛花苷注射剂市场的复合年增长率将达到4.5%。该市场的主要驱动因素包括心臟衰竭盛行率的上升、强心配配糖体需求的增加以及老年人口的成长。

• Lucintel 预测，按类型学名药在预测期内将出现高速成长。
• 按用途类型来看，医院预计将实现更高的成长。
• 按地区划分，预计亚太地区将在预测期内实现最高成长。

毛花苷注射液市场新趋势

去甲毛花苷注射剂市场正引领临床实务和药物研发的持续发展。儘管其作用已得到充分认可，但新兴趋势反映出人们正在不断努力优化去甲毛花苷的使用，应对其独特的挑战，并探索潜在的新型应用，尤其是在心血管疾病管理和药物再利用领域。

• 优化剂量和监测：为了尽量缩小去毛花苷的治疗指数，降低副作用的风险，确保更安全的临床应用，仍然需要注重精确的剂量调整和加强病患监测，包括电解质水平和肾功能。
• 重视急性心臟衰竭的治疗：去甲毛花苷注射液在严重郁血性心臟衰竭衰竭的急性治疗中发挥重要作用，尤其是在需要快速起效的情况下。这一趋势凸显了去甲毛花苷在急诊循环系统中的持续重要性。
• 肿瘤学再利用：新研究表明，去毛花苷与其他配糖体一样，可能具有抗癌活性。这一趋势探索了去毛花苷在前列腺癌和其他恶性肿瘤治疗中的应用潜力，为其在传统心臟适应症之外的市场成长开闢了新的途径。
• 新剂型的开发：儘管除毛花苷主要为注射液，但也存在开发新剂型和输送系统的机会，包括提高生物有效性的舌下或颊片，或可以提高患者便利性和依从性的缓释性。
• 融入数位健康平台：远端监控和远端医疗等数位健康技术在心血管疾病管理中的日益普及，或将为去毛花苷带来新的机会。融入这些平台或将提升患者的参与度和依从性，从而支持去毛花苷的持续使用。

这些趋势正在重塑除毛苷注射市场，一方面巩固了除毛苷在急性护理领域的利基市场，另一方面也谨慎地探索新的治疗途径。在新药不断涌现的背景下，对安全性、更优的给药方式和再利用潜力的关注，确保了除毛苷在製药业专业且持续的市场地位。

去乙酰毛花苷注射液市场近期趋势

循环系统医学的广泛发展以及去毛花苷在某些心臟疾病中的持续效用推动了去毛花苷注射剂市场的发展。这些发展的重点在于，在新疗法不断涌现的情况下，确保其安全有效使用，解决供应链稳定性问题，并探索超越传统适应症的药理特性。

• 急性心臟病护理的持续需求：去甲毛花苷注射液仍然是治疗急性郁血性心臟衰竭衰竭和某些类型的突发性心律不整的重要药物，特别是在快速干预至关重要的情况下，导致急诊和重症加护中的持续需求。
• 重点缓解药品短缺：鑑于除毛苷注射液在急性病环境中的重要性，以及为了确保患者能够持续获得药物，我们继续专注于预防和管理潜在的药物短缺，这对于较老、盈利较低的药品来说通常是一个挑战。
• 抗癌活性：近期研究正积极探索去毛花苷作为抗癌药物的潜力，尤其是在前列腺癌细胞。这项药物再利用研究代表着在探索心臟作用以外的全新治疗应用方面取得的重要进展。
• 强调药物安全检测警戒：由于脱毛苷的治疗指数较窄，且有药物交互作用和副作用的可能性，因此在临床实务中强调药物安全检测和仔细的病患监测，以确保安全用药。
• 优化全球供应链：製造商和经销商正在努力优化除毛苷注射液的全球供应链，以确保不同地区的持续供应，特别是在经常将其用作心臟急救药物的国家。

这些发展共同影响着去毛花苷注射液市场，巩固了其在急性护理中的地位，同时也积极探索新的治疗可能性。对安全性、供应链稳定性和药物再利用的关注，确保了去毛花苷注射液在心血管治疗领域持续发展，并保持其重要性。

目录

第一章执行摘要

第二章 市场概述

• 背景和分类
• 供应链

第三章：市场趋势与预测分析

• 宏观经济趋势与预测
• 产业驱动力与挑战
• PESTLE分析
• 专利分析
• 法规环境

第四章 去乙酰毛花苷注射液市场（按类型）

• 概述
• 按类型进行吸引力分析
• 原始药物：趋势与预测（2019-2031）
• 学名药：趋势与预测（2019-2031）

5. 全球去乙酰毛花苷注射液市场（依应用）

• 概述
• 按用途进行吸引力分析
• 医院：趋势与预测（2019-2031）
• 诊所：趋势与预测（2019-2031）
• 其他：趋势与预测（2019-2031）

第六章区域分析

• 概述
• 全球去乙酰毛花苷注射液市场（按地区）

7. 北美除毛苷注射液市场

• 概述
• 北美去乙酰毛花苷注射剂市场（按类型）
• 北美去乙酰毛花苷注射液市场应用状况
• 美国去乙酰毛花苷注射液市场
• 墨西哥的Deslanoside注射市场
• 加拿大去乙酰毛花苷注射液市场

8. 欧洲去乙酰毛花苷注射液市场

• 概述
• 欧洲去乙酰毛花苷注射剂市场（按类型）
• 欧洲去乙酰毛花苷注射液市场（按应用）
• 德国去乙酰毛花苷注射液市场
• 法国Deslanoside注射市场
• 西班牙Deslanoside注射市场
• 义大利Deslanoside注射市场
• 英国去乙酰毛花苷注射液市场

9. 亚太地区毛花苷注射剂市场

• 概述
• 亚太地区去乙酰毛花苷注射液市场（按类型）
• 亚太地区去乙酰毛花苷注射液市场应用情况
• 日本去乙酰毛花苷注射液市场
• 印度去乙酰毛花苷注射液市场
• 中国毛花苷注射液市场
• 韩国去乙酰毛花苷注射液市场
• 印尼Deslanoside注射剂市场

第十章 世界其他地区去乙酰毛花苷注射液市场

• 概述
• 世界其他地区去乙酰毛花苷注射液市场（按类型）
• 世界其他地区去乙酰毛花苷注射液市场（按应用）
• 中东去乙酰毛花苷注射液市场
• 南美洲除毛苷注射液市场
• 非洲去乙酰毛花苷注射液市场

第十一章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析
  • 竞争对手之间的竞争
  • 买方的议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 新进入者的威胁
• 市场占有率分析

第十二章机会与策略分析

• 价值链分析
• 成长机会分析
  • 按类型分類的成长机会
  • 按应用分類的成长机会
• 全球去乙酰毛花苷注射液市场的新趋势
• 战略分析
  • 新产品开发
  • 认证和许可
  • 合併、收购、协议、合作和合资企业

第十三章：价值链主要企业的公司简介

• Competitive Analysis
• ShanghaizhaoHui Pharmaceutical
• Shanghai Xudong Haipu Pharmaceutical
• Chengdu Brilliant Pharmaceutical
• Viwit Pharmaceuticals
• Ryvis Pharma

第十四章 附录

• 图表目录
• 表格列表
• 调查方法
• 免责声明
• 版权
• 简称和技术单位
• 关于美国
• 美国调查

The future of the global deslanoside injection market looks promising with opportunities in the hospital and clinic markets. The global deslanoside injection market is expected to grow with a CAGR of 4.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of heart failure, the rising demand for cardiac glycosides, and the growing elderly patient population.

• Lucintel forecasts that, within the type category, generic drug is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Deslanoside Injection Market

The deslanoside injection market is navigating a landscape of evolving clinical practices and pharmaceutical advancements. Despite its established role, emerging trends reflect a continuous effort to optimize its use, address inherent challenges, and explore potential new applications, particularly in the context of cardiovascular disease management and drug repurposing.

• Optimized Dosage and Monitoring: There is a continued focus on precise dosage adjustment and enhanced patient monitoring, including electrolyte levels and renal function, to minimize deslanoside's narrow therapeutic index and reduce the risk of adverse effects, ensuring safer clinical application.
• Emphasis on Acute Heart Failure Management: Deslanoside injection maintains its critical role in the acute management of severe congestive heart failure, particularly when rapid onset of action is required. This trend highlights its continued relevance in emergency cardiology.
• Drug Repurposing for Oncology: Emerging research suggests deslanoside, like other cardiac glycosides, may exhibit anticancer activity. This trend explores its potential repurposing for prostate cancer and other malignancies, offering a novel avenue for market growth beyond its traditional cardiac indications.
• Development of Novel Formulations: While primarily an injectable, opportunities exist for developing novel formulations and delivery systems for deslanoside. This could include sublingual or buccal tablets to improve bioavailability or sustained-release options, potentially enhancing patient convenience and adherence.
• Integration into Digital Health Platforms: The increasing adoption of digital health technologies, such as remote monitoring and telemedicine, in cardiovascular disease management could create new opportunities for deslanoside. Integration into these platforms could improve patient engagement and adherence, supporting its continued use.

These trends are collectively reshaping the deslanoside injection market by reinforcing its niche in acute care, while cautiously exploring new therapeutic avenues. The focus on safety, improved delivery, and potential repurposing, amidst a landscape of newer drugs, ensures its continued, albeit specialized, presence in the pharmaceutical industry.

Recent Developments in the Deslanoside Injection Market

The deslanoside injection market has seen recent developments driven by its ongoing utility in specific cardiac conditions, alongside the broader evolution of cardiovascular medicine. These advancements focus on ensuring its safe and effective use, addressing supply chain stability, and exploring its pharmacological properties beyond its traditional indications, despite the advent of newer therapeutic agents.

• Sustained Demand in Acute Cardiac Care: Deslanoside injection continues to be a vital medication for acute congestive heart failure and certain rapid arrhythmias, especially where prompt intervention is critical. This sustains its demand in emergency and critical care settings.
• Focus on Drug Shortage Mitigation: Given its importance in acute situations, there is an ongoing focus on preventing and managing potential drug shortages of deslanoside injection, often a challenge for older, less profitable medications, to ensure continuous patient access.
• Research into Anticancer Properties: Recent studies are actively investigating deslanoside's potential as an anticancer agent, particularly in prostate cancer cells. This research into drug repurposing represents a significant development, exploring new therapeutic applications beyond its cardiac effects.
• Emphasis on Pharmacovigilance: Due to deslanoside's narrow therapeutic index and potential for drug interactions and adverse effects, there is a heightened emphasis on pharmacovigilance and careful patient monitoring in clinical practice to ensure its safe administration.
• Global Supply Chain Optimization: Manufacturers and distributors are working to optimize global supply chains for deslanoside injection, ensuring consistent availability across different regions, particularly in countries where it remains a frequently used cardiac emergency drug.

These developments are collectively impacting the deslanoside injection market by solidifying its role in acute care, while cautiously exploring new therapeutic potential. The emphasis on safety, supply chain stability, and drug repurposing ensures its ongoing relevance, even as the cardiovascular treatment landscape continues to evolve.

Strategic Growth Opportunities in the Deslanoside Injection Market

The deslanoside injection market, while mature, presents strategic growth opportunities by focusing on its unique pharmacological properties and addressing specific clinical needs. By leveraging its rapid onset and established efficacy in acute settings, alongside exploring novel therapeutic avenues, manufacturers can ensure its continued relevance and potentially expand its market footprint in a competitive landscape.

• Acute Decompensated Heart Failure: Capitalizing on deslanoside's rapid inotropic effect for intravenous administration in acute decompensated heart failure is a key growth opportunity, particularly in emergency and critical care settings where immediate improvement in cardiac function is paramount.
• Rapid Ventricular Rate Control in Atrial Fibrillation: For patients with rapid ventricular response in atrial fibrillation where other agents are contraindicated or ineffective, deslanoside injection offers a valuable growth opportunity due to its ability to quickly slow the heart rate and improve hemodynamics.
• Repurposing in Oncology (e.g., Prostate Cancer): Pursuing clinical trials and research for deslanoside's potential anticancer effects, especially against prostate cancer cells, represents a significant growth opportunity for drug repurposing, potentially opening entirely new therapeutic markets for the drug.
• Role in Resource-Limited Settings: In developing economies or resource-limited settings where newer, more expensive cardiovascular drugs may not be readily available, deslanoside's cost-effectiveness and established efficacy for acute conditions present a vital growth opportunity for essential medicine provision.
• Niche Use in Pediatric Cardiology: While requiring careful dosing, deslanoside may find specific, though limited, growth opportunities in pediatric cardiology for certain acute heart failure or arrhythmia conditions in children, where its rapid action can be clinically advantageous.

These strategic growth opportunities are impacting the deslanoside injection market by reinforcing its critical role in acute care settings and exploring promising new therapeutic avenues. By focusing on these specific applications, manufacturers can ensure its continued demand, contribute to public health, and potentially expand its overall market value.

Deslanoside Injection Market Driver and Challenges

The deslanoside injection market is influenced by a blend of drivers supporting its continued use and significant challenges impeding broader expansion. Major drivers include its rapid action in acute cardiac emergencies and its established clinical efficacy. However, the market faces hurdles such as its narrow therapeutic window, the risk of drug interactions, and the emergence of newer, often safer, cardiovascular drugs.

The factors responsible for driving the deslanoside injection market include:

1. Rapid Onset of Action: Deslanoside's quick onset of action when administered intravenously makes it invaluable for managing acute cardiac emergencies, such as severe congestive heart failure, where immediate therapeutic effect is crucial for patient stabilization.

2. Established Clinical Efficacy: Despite the development of newer drugs, deslanoside has a long history of proven efficacy in improving myocardial contractility and controlling ventricular rates in specific cardiac arrhythmias, maintaining its clinical relevance.

3. Affordability and Accessibility (in some regions): As an older, generic drug, deslanoside injection is often more affordable and readily accessible compared to newer, patented cardiovascular medications, particularly in developing economies, driving its continued use.

4. Use in Specific Clinical Scenarios: Deslanoside remains a valuable option in specific clinical scenarios where other treatments might be ineffective or contraindicated, ensuring its continued demand as a niche, yet essential, therapeutic agent.

5. Global Burden of Cardiovascular Diseases: The increasing global prevalence of cardiovascular diseases, including heart failure and arrhythmias, contributes to an underlying demand for various cardiac medications, including deslanoside for acute management.

Challenges in the deslanoside injection market are:

1. Narrow Therapeutic Index and Toxicity Risk: Deslanoside has a very narrow therapeutic window, meaning the effective dose is close to the toxic dose. This necessitates careful monitoring and dosage adjustment, increasing the risk of adverse effects and limiting its widespread use.

2. Drug Interactions and Adverse Effects: Deslanoside is prone to numerous drug interactions with commonly prescribed medications and can cause significant adverse effects, including arrhythmias and gastrointestinal issues, requiring meticulous patient management.

3. Competition from Newer, Safer Drugs: The market faces significant competition from a wide range of newer cardiovascular drugs (e.g., beta-blockers, ACE inhibitors, ARBs) that often offer a broader therapeutic window, fewer side effects, and more convenient dosing, leading to a decline in deslanoside's overall market share.

The market is driven by its acute efficacy and affordability, securing its place in specific cardiac emergencies. However, its narrow therapeutic index, interaction risks, and competition from newer drugs present significant challenges. Sustained market presence hinges on careful clinical application and ongoing efforts to address its inherent limitations.

List of Deslanoside Injection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies deslanoside injection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the deslanoside injection companies profiled in this report include-

• ShanghaizhaoHui Pharmaceutical
• Shanghai Xudong Haipu Pharmaceutical
• Chengdu Brilliant Pharmaceutical
• Viwit Pharmaceuticals
• Ryvis Pharma

Deslanoside Injection Market by Segment

The study includes a forecast for the global deslanoside injection market by type, application, and region.

Deslanoside Injection Market by Type [Value from 2019 to 2031]:

• Original Drug
• Generic Drug

Deslanoside Injection Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Others

Deslanoside Injection Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Deslanoside Injection Market

The deslanoside injection market, primarily used for acute congestive heart failure and cardiac arrhythmias, is experiencing evolving dynamics. While newer cardiovascular drugs have emerged, deslanoside retains a niche due to its rapid onset and specific mechanism of action. Recent developments across major economies reflect shifts in clinical practice, manufacturing focus, and ongoing challenges related to its inherent properties and therapeutic alternatives.

• United States: The US market for deslanoside injection sees its use driven by acute cardiac emergencies and specific guidelines. Recent developments include continued careful monitoring for adverse effects and drug interactions due to its narrow therapeutic index, and a focus on maintaining supply chain stability for this essential, albeit specialized, medication, amidst a broader shift to newer cardiovascular treatments.
• China: China's deslanoside injection market is influenced by its large patient population and domestic pharmaceutical production capabilities. Recent developments include a focus on ensuring local production and supply of essential medicines, and a growing emphasis on managing drug shortages which can impact the availability of older, low-cost drugs like deslanoside, despite their clinical utility.
• Germany: The German market for deslanoside injection aligns with its strong healthcare infrastructure and emphasis on high-quality pharmaceuticals. Recent developments include its continued use in specific acute cardiac settings, alongside a broader trend of increasing R&D in the pharmaceutical sector and rising prevalence of chronic diseases, though newer treatments often take precedence.
• India: India's deslanoside injection market is characterized by increasing local production and a growing healthcare sector. Recent developments include efforts to ensure the availability of essential cardiac medications, and an expanding focus on managing cardiovascular diseases, driving demand for various treatments, including deslanoside for acute situations, as part of its extensive healthcare system.
• Japan: Japan's market for deslanoside injection is shaped by its advanced healthcare system and stringent quality control. Recent developments likely include adherence to its pharmacopoeia standards for quality assurance, and a focus on clinical efficacy and patient safety given its potent nature, while research may explore its role in specific cardiac conditions.

Features of the Global Deslanoside Injection Market

• Market Size Estimates: Deslanoside injection market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Deslanoside injection market size by type, application, and region in terms of value ($B).
• Regional Analysis: Deslanoside injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the deslanoside injection market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the deslanoside injection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the deslanoside injection market by type (original drug and generic drug), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Deslanoside Injection Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Original Drug: Trends and Forecast (2019-2031)
• 4.4 Generic Drug: Trends and Forecast (2019-2031)

5. Global Deslanoside Injection Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Clinic: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Deslanoside Injection Market by Region

7. North American Deslanoside Injection Market

• 7.1 Overview
• 7.2 North American Deslanoside Injection Market by Type
• 7.3 North American Deslanoside Injection Market by Application
• 7.4 United States Deslanoside Injection Market
• 7.5 Mexican Deslanoside Injection Market
• 7.6 Canadian Deslanoside Injection Market

8. European Deslanoside Injection Market

• 8.1 Overview
• 8.2 European Deslanoside Injection Market by Type
• 8.3 European Deslanoside Injection Market by Application
• 8.4 German Deslanoside Injection Market
• 8.5 French Deslanoside Injection Market
• 8.6 Spanish Deslanoside Injection Market
• 8.7 Italian Deslanoside Injection Market
• 8.8 United Kingdom Deslanoside Injection Market

9. APAC Deslanoside Injection Market

• 9.1 Overview
• 9.2 APAC Deslanoside Injection Market by Type
• 9.3 APAC Deslanoside Injection Market by Application
• 9.4 Japanese Deslanoside Injection Market
• 9.5 Indian Deslanoside Injection Market
• 9.6 Chinese Deslanoside Injection Market
• 9.7 South Korean Deslanoside Injection Market
• 9.8 Indonesian Deslanoside Injection Market

10. ROW Deslanoside Injection Market

• 10.1 Overview
• 10.2 ROW Deslanoside Injection Market by Type
• 10.3 ROW Deslanoside Injection Market by Application
• 10.4 Middle Eastern Deslanoside Injection Market
• 10.5 South American Deslanoside Injection Market
• 10.6 African Deslanoside Injection Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Deslanoside Injection Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 ShanghaizhaoHui Pharmaceutical
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Shanghai Xudong Haipu Pharmaceutical
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Chengdu Brilliant Pharmaceutical
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Viwit Pharmaceuticals
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Ryvis Pharma
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us

List of Figures

• Figure 1.1: Trends and Forecast for the Global Deslanoside Injection Market
• Figure 2.1: Usage of Deslanoside Injection Market
• Figure 2.2: Classification of the Global Deslanoside Injection Market
• Figure 2.3: Supply Chain of the Global Deslanoside Injection Market
• Figure 2.4: Driver and Challenges of the Deslanoside Injection Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Deslanoside Injection Market ($B) by Type
• Figure 4.3: Forecast for the Global Deslanoside Injection Market ($B) by Type
• Figure 4.4: Trends and Forecast for Original Drug in the Global Deslanoside Injection Market (2019-2031)
• Figure 4.5: Trends and Forecast for Generic Drug in the Global Deslanoside Injection Market (2019-2031)
• Figure 5.1: Global Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Deslanoside Injection Market ($B) by Application
• Figure 5.3: Forecast for the Global Deslanoside Injection Market ($B) by Application
• Figure 5.4: Trends and Forecast for Hospital in the Global Deslanoside Injection Market (2019-2031)
• Figure 5.5: Trends and Forecast for Clinic in the Global Deslanoside Injection Market (2019-2031)
• Figure 5.6: Trends and Forecast for Others in the Global Deslanoside Injection Market (2019-2031)
• Figure 6.1: Trends of the Global Deslanoside Injection Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Deslanoside Injection Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Deslanoside Injection Market (2019-2031)
• Figure 7.2: North American Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 7.5: North American Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Deslanoside Injection Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Deslanoside Injection Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Deslanoside Injection Market (2019-2031)
• Figure 8.2: European Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 8.5: European Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Deslanoside Injection Market (2019-2031)
• Figure 9.2: APAC Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Deslanoside Injection Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Deslanoside Injection Market (2019-2031)
• Figure 10.2: ROW Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Deslanoside Injection Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Deslanoside Injection Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Deslanoside Injection Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Deslanoside Injection Market
• Figure 11.2: Market Share (%) of Top Players in the Global Deslanoside Injection Market (2024)
• Figure 12.1: Growth Opportunities for the Global Deslanoside Injection Market by Type
• Figure 12.2: Growth Opportunities for the Global Deslanoside Injection Market by Application
• Figure 12.3: Growth Opportunities for the Global Deslanoside Injection Market by Region
• Figure 12.4: Emerging Trends in the Global Deslanoside Injection Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Deslanoside Injection Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Deslanoside Injection Market by Region
• Table 1.3: Global Deslanoside Injection Market Parameters and Attributes
• Table 3.1: Trends of the Global Deslanoside Injection Market (2019-2024)
• Table 3.2: Forecast for the Global Deslanoside Injection Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Deslanoside Injection Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Deslanoside Injection Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Deslanoside Injection Market (2025-2031)
• Table 4.4: Trends of Original Drug in the Global Deslanoside Injection Market (2019-2024)
• Table 4.5: Forecast for Original Drug in the Global Deslanoside Injection Market (2025-2031)
• Table 4.6: Trends of Generic Drug in the Global Deslanoside Injection Market (2019-2024)
• Table 4.7: Forecast for Generic Drug in the Global Deslanoside Injection Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Deslanoside Injection Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Deslanoside Injection Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Deslanoside Injection Market (2025-2031)
• Table 5.4: Trends of Hospital in the Global Deslanoside Injection Market (2019-2024)
• Table 5.5: Forecast for Hospital in the Global Deslanoside Injection Market (2025-2031)
• Table 5.6: Trends of Clinic in the Global Deslanoside Injection Market (2019-2024)
• Table 5.7: Forecast for Clinic in the Global Deslanoside Injection Market (2025-2031)
• Table 5.8: Trends of Others in the Global Deslanoside Injection Market (2019-2024)
• Table 5.9: Forecast for Others in the Global Deslanoside Injection Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Deslanoside Injection Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Deslanoside Injection Market (2025-2031)
• Table 7.1: Trends of the North American Deslanoside Injection Market (2019-2024)
• Table 7.2: Forecast for the North American Deslanoside Injection Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Deslanoside Injection Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Deslanoside Injection Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Deslanoside Injection Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Deslanoside Injection Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Deslanoside Injection Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Deslanoside Injection Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Deslanoside Injection Market (2019-2031)
• Table 8.1: Trends of the European Deslanoside Injection Market (2019-2024)
• Table 8.2: Forecast for the European Deslanoside Injection Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Deslanoside Injection Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Deslanoside Injection Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Deslanoside Injection Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Deslanoside Injection Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Deslanoside Injection Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Deslanoside Injection Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Deslanoside Injection Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Deslanoside Injection Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Deslanoside Injection Market (2019-2031)
• Table 9.1: Trends of the APAC Deslanoside Injection Market (2019-2024)
• Table 9.2: Forecast for the APAC Deslanoside Injection Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Deslanoside Injection Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Deslanoside Injection Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Deslanoside Injection Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Deslanoside Injection Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Deslanoside Injection Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Deslanoside Injection Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Deslanoside Injection Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Deslanoside Injection Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Deslanoside Injection Market (2019-2031)
• Table 10.1: Trends of the ROW Deslanoside Injection Market (2019-2024)
• Table 10.2: Forecast for the ROW Deslanoside Injection Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Deslanoside Injection Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Deslanoside Injection Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Deslanoside Injection Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Deslanoside Injection Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Deslanoside Injection Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Deslanoside Injection Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Deslanoside Injection Market (2019-2031)
• Table 11.1: Product Mapping of Deslanoside Injection Suppliers Based on Segments
• Table 11.2: Operational Integration of Deslanoside Injection Manufacturers
• Table 11.3: Rankings of Suppliers Based on Deslanoside Injection Revenue
• Table 12.1: New Product Launches by Major Deslanoside Injection Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Deslanoside Injection Market